Shan Q, Qiu J, Dong Z, Xu X, Zhang S, Ma J
Adv Sci (Weinh). 2024; 11(45):e2405490.
PMID: 39401416
PMC: 11615829.
DOI: 10.1002/advs.202405490.
Moon H, Eccles J, Kim S, Kim K, Kim Y, Rehman J
J Allergy Clin Immunol. 2023; 152(5):1141-1152.e2.
PMID: 37562753
PMC: 10923196.
DOI: 10.1016/j.jaci.2023.07.016.
Raith M, Swoboda I
Front Allergy. 2023; 4:1181675.
PMID: 37255542
PMC: 10225653.
DOI: 10.3389/falgy.2023.1181675.
Satala D, Bras G, Kozik A, Rapala-Kozik M, Karkowska-Kuleta J
J Fungi (Basel). 2023; 9(1).
PMID: 36675942
PMC: 9865821.
DOI: 10.3390/jof9010121.
Robles T, Bai S, Meng Y
Int J Behav Med. 2022; 30(3):398-408.
PMID: 35655059
PMC: 10167194.
DOI: 10.1007/s12529-022-10103-8.
Nasal Epithelial Barrier Integrity and Tight Junctions Disruption in Allergic Rhinitis: Overview and Pathogenic Insights.
Nur Husna S, Tan H, Md Shukri N, Mohd Ashari N, Wong K
Front Immunol. 2021; 12:663626.
PMID: 34093555
PMC: 8176953.
DOI: 10.3389/fimmu.2021.663626.
The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic?.
Villena J, Kitazawa H
Front Physiol. 2020; 11:699.
PMID: 32670091
PMC: 7326040.
DOI: 10.3389/fphys.2020.00699.
Combinatorial IL-17RB, ST2, and TSLPR Signaling in Dendritic Cells of Patients With Allergic Rhinitis.
Zheng R, Chen Y, Shi J, Wang K, Huang X, Sun Y
Front Cell Dev Biol. 2020; 8:207.
PMID: 32309281
PMC: 7145954.
DOI: 10.3389/fcell.2020.00207.
Non-Reflex Defense Mechanisms of Upper Airway Mucosa: Possible Clinical Application.
Pedan H, Janosova V, Hajtman A, Calkovsky V
Physiol Res. 2020; 69(Suppl 1):S55-S67.
PMID: 32228012
PMC: 8604065.
DOI: 10.33549/physiolres.934404.
Current Understanding of Nasal Epithelial Cell Mis-Differentiation.
Scherzad A, Hagen R, Hackenberg S
J Inflamm Res. 2019; 12:309-317.
PMID: 31853193
PMC: 6916682.
DOI: 10.2147/JIR.S180853.
A method for the generation of large numbers of dendritic cells from CD34+ hematopoietic stem cells from cord blood.
Bedke N, Swindle E, Molnar C, Holt P, Strickland D, Roberts G
J Immunol Methods. 2019; 477:112703.
PMID: 31711888
PMC: 6983936.
DOI: 10.1016/j.jim.2019.112703.
Elevated expression of IL-17RB and ST2 on myeloid dendritic cells is associated with a Th2-skewed eosinophilic inflammation in nasal polyps.
Zheng R, Wang D, Wang K, Gao W, Yang Q, Jiang L
Clin Transl Allergy. 2018; 8:50.
PMID: 30519393
PMC: 6263180.
DOI: 10.1186/s13601-018-0237-4.
Primary human nasal epithelial cells: a source of poly (I:C) LMW-induced IL-6 production.
Ramezanpour M, Bolt H, Psaltis A, Wormald P, Vreugde S
Sci Rep. 2018; 8(1):11325.
PMID: 30054566
PMC: 6063928.
DOI: 10.1038/s41598-018-29765-0.
Fundamental role of dendritic cells in inducing Th2 responses.
Kim B, Kim T
Korean J Intern Med. 2018; 33(3):483-489.
PMID: 29502361
PMC: 5943655.
DOI: 10.3904/kjim.2016.227.
Urban particulate matter stimulation of human dendritic cells enhances priming of naive CD8 T lymphocytes.
Pfeffer P, Ho T, Mann E, Kelly F, Sehlstedt M, Pourazar J
Immunology. 2017; 153(4):502-512.
PMID: 29044495
PMC: 5838419.
DOI: 10.1111/imm.12852.
Protective barrier properties of Rhinosectan spray (containing xyloglucan) on an organotypic 3D airway tissue model (MucilAir): results of an in vitro study.
De Servi B, Ranzini F, Pique N
Allergy Asthma Clin Immunol. 2017; 13:37.
PMID: 28811823
PMC: 5553660.
DOI: 10.1186/s13223-017-0209-6.
The many ways tissue phagocytes respond to dying cells.
Blander J
Immunol Rev. 2017; 277(1):158-173.
PMID: 28462530
PMC: 5721677.
DOI: 10.1111/imr.12537.
Expression and regulation of immune-modulatory enzyme indoleamine 2,3-dioxygenase (IDO) by human airway epithelial cells and its effect on T cell activation.
Aldajani W, Salazar F, Sewell H, Knox A, Ghaemmaghami A
Oncotarget. 2016; 7(36):57606-57617.
PMID: 27613847
PMC: 5295376.
DOI: 10.18632/oncotarget.11586.
Unique Transcompartmental Bridge: Antigen-Presenting Cells Sampling across Endothelial and Mucosal Barriers.
Allen F, Tong A, Huang A
Front Immunol. 2016; 7:231.
PMID: 27375624
PMC: 4901051.
DOI: 10.3389/fimmu.2016.00231.
Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies.
Lehmann C, Heger L, Heidkamp G, Baranska A, Luhr J, Hoffmann A
Vaccines (Basel). 2016; 4(2).
PMID: 27043640
PMC: 4931625.
DOI: 10.3390/vaccines4020008.